cGP is endogenous to the human body and plays a key role in regulating IGF-1 function, a life-essential hormone that is crucial for growth and development. As we age, the body’s production of cGP is just not sufficient to fulfil the body’s needs contributing to symptoms such as cognitive decline, compromised mood, and poor sleep.
Impaired IGF-1 levels have been implicated in neurodegenerative diseases, metabolic syndrome and vascular conditions. cGP supplementation provides an opportunity to restore normal IGF-1 function thereby supporting symptom management in these conditions, reverse vascular degeneration and slow the progression of neurodegenerative decline.